MEI Pharma (MEIP) Appoints Christine A. White to its Board

Go back to MEI Pharma (MEIP) Appoints Christine A. White to its Board

MEI Pharma Announces Changes to Board of Directors

September 22, 2022 8:00 AM EDT

SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Christine A. White, M.D., has decided to retire and thus does not intend to stand for reelection at the Companys fiscal year 2023 annual meeting of stockholders after a seven-year tenure as chair of the board and 12 years total serving as a director. Charles V. Baltic III, J.D., who has served on the board since 2011, has been elected to replace Dr. White as chair of the board. Dr.... More